Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Theseus Pharmaceuticals, Inc. (THRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  0.00.00.0 
Cost of goods sold  0.00.00.0 
Gross profit  0.00.00.0 
Selling, general and administrative   [+]18.49.00.9 
Research and development  35.718.36.0 
EBITDA   [+]-54.0-27.3-6.8 
Depreciation and amortization  0.10.00.0 
EBIT   [+]-54.1-27.3-6.8 
Other income (expense), net   [+]3.50.0-5.2 
Pre-tax income  -50.6-27.3-12.0 
Income taxes  0.00.00.0 
            Tax rate  0.0%0.0%0.0% 
Net income  -50.6-27.3-12.0 
   
Basic EPS   [+]($1.31)($2.84)($21.10) 
Diluted EPS   [+]($1.31)($2.84)($21.10) 
   
Shares outstanding (basic)   [+]38.59.60.6 
Shares outstanding (diluted)   [+]38.59.60.6 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy